Milan, Italy / Ulm, Germany – July 2018 –
Exom Group, the Expert Digital CRO announced and welcomed Patrick McManus as new Chief Development Officer.
Patrick joins Exom bringing more than 10 years of experience in Business Development in the CRO business. Holding a diploma in Business Administration and Computational Sciences from the Academy of Public and Business Administration in Munich, he is now pursuing his MSc in Clinical Research at the Danube University Krems.
During his career Patrick gained a solid understanding of all aspects of clinical trials and deep knowledge in Business Development. He held a leading position in a mid-size CRO, being responsible for establishing the company on the market, as well as further pursuing the company’s growth.
Dr. Luigi Visani, CEO of Exom Group said that “hiring Patrick corresponds with Exom’s business growth strategy, that is of bringing people with solid experience, expertise and visions together and to establish Exom as the leading expert international CRO in digital clinical trials.”
Among the new responsibilities Patrick McManus can expect to manage at Exom, one of the main challenges, is the education of the clients in the benefits of newly developed technologies, which can improve and benefit the conduct of clinical trials with increased quality and performance at a very competitive price.